Work

Improvements in Health-related Quality of Life and Symptoms in Patients With Previously Untreated Chronic Lymphocytic Leukemia: Final Results From the Phase II GIBB Study of the Combination of Obinutuzumab and Bendamustine

Year: 2021

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2021.09.008

Authors: Alexey V. Danilov, Habte A. Yimer, Michael A. Boxer, John M. Burke, Sunil Babu, Jia Li, Yong Mun, Peter C. Trask, Anthony S. Masaquel, Jeff P. Sharman

Institutions: City Of Hope National Medical Center, City of Hope, Texas Oncology, Arizona Oncology, Rocky Mountain Cancer Centers, Fort Wayne Medical Institute, Genentech, Willamette Valley Cancer Institute and Research Center

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2986157973

FWCI:

Cites: 27

Cited by: 2

Related to: 10